手术前的全身化疗,包括免疫检查点抑制剂,用于患有瘤相关皮肤肌炎的患者
Yukino Kawamura1,2, Akihiko Shimomura1,2, Tomoko Taniyama1
1Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Case reports in oncology
|February 21, 2025
概括
免疫检查点抑制剂 (ICI) 可以安全地与化疗一起用于乳腺癌患者,这些患者也患有自身免疫性疾病,如皮肤肌炎. 这种方法在管理复杂案件方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 免疫检查点抑制剂 (ICI) 增强抗癌免疫力,但可能导致与免疫相关的不良事件.
- 自身免疫性疾病涉及免疫系统对自身组织的攻击,导致炎症和损伤.
- 关于ICI在患有活跃自身免疫性疾病的患者中使用的数据有限,这给管理带来了挑战.
相关概念视频
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
131
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
131